What are the recommended loading and maintenance doses of colistin (polymyxin E) injection for a patient with impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Colistin Dosing: Loading and Maintenance Doses

Loading Dose (Stat Dose)

Administer a loading dose of 9 million international units (IU) of colistin methanesulfonate (CMS) intravenously to all patients regardless of renal function. 1, 2, 3

  • This loading dose is equivalent to approximately 5 mg/kg or 300 mg colistin base activity (CBA) 2, 3
  • The loading dose is critical because colistin displays a relatively long half-life in relation to dosing intervals, and without it, therapeutic plasma concentrations may not be achieved for 2-3 days 1, 2
  • Administer the loading dose slowly over 3-5 minutes 4
  • Do not reduce the loading dose for renal impairment - the same 9 million IU loading dose applies to all patients, including those on dialysis 1, 2, 5

Maintenance Doses

For Patients with Normal Renal Function (CrCl ≥80 mL/min)

Administer 4.5 million IU every 12 hours (total 9 million IU/day) for critically ill patients with severe infections. 1, 2, 3

  • Alternative dosing: 2.5-5 mg/kg/day divided into 2-4 doses 4, 3
  • The FDA-approved dosing range is 2.5-5 mg/kg per day in 2-4 divided doses, but critically ill patients typically require the higher end 4
  • Extended 4-hour infusions may optimize pharmacokinetic/pharmacodynamic properties 2, 3

For Patients with Renal Impairment

Adjust maintenance doses according to creatinine clearance using the following algorithm: 1, 4

  • Mild impairment (CrCl 50-79 mL/min): 2.5-3.8 mg/kg divided into 2 doses per day 4
  • Moderate impairment (CrCl 30-49 mL/min): 2.5 mg/kg once daily or divided into 2 doses per day 4
  • Severe impairment (CrCl 10-29 mL/min): 1.5 mg/kg every 36 hours 4

Alternative formula-based dosing for maintenance: 2.5 mg × (1.5 × CrCl + 30) IV every 12 hours 1

For Patients on Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT):

  • Administer at least 9 million IU/day (4.5 million IU every 12 hours) 1, 2
  • Use the normal loading dose of 9 million IU 1, 2
  • Do not reduce doses for CRRT as extracorporeal clearance can cause substantial removal of colistin 6

Intermittent Hemodialysis:

  • Administer 2 million IU every 12 hours after the normal loading dose 1, 2
  • Schedule dialysis toward the end of a colistin dosage interval 1, 2

Critical Dosing Conversions

  • 1 million IU of colistin = approximately 80 mg of colistimethate sodium (CMS) = approximately 30 mg colistin base activity 1, 2, 3
  • Colistin is administered as the inactive prodrug CMS, which converts to active colistin in vivo 2, 3, 7

Important Clinical Pitfalls

Avoid these common errors:

  • Never skip the loading dose - without it, suboptimal plasma concentrations persist for 2-3 days, potentially leading to treatment failure 1, 2
  • Do not reduce the loading dose for renal impairment - only maintenance doses require adjustment 1, 2, 5
  • Do not rely solely on serum creatinine - use calculated creatinine clearance (CKD-EPI formula) for dose adjustments, as serum creatinine can be misleading in critically ill patients 8
  • Monitor renal function closely - check at baseline and 2-3 times per week during treatment, as acute kidney injury is a major factor related to clinical failure and mortality 2, 5
  • Use ideal body weight for obese patients when calculating doses 4

Alternative: Polymyxin B

Consider polymyxin B as an alternative, particularly in patients with renal impairment or on CRRT. 1, 5

  • Loading dose: 2-2.5 mg/kg regardless of renal function 1, 5
  • Maintenance dose: 1.5-3 mg/kg/day (or 2.5-3.0 mg/kg/day divided in 2 daily doses) 1, 5
  • No dose adjustment needed for CRRT 1, 5
  • Lower incidence of nephrotoxicity compared to colistin (11.8% vs 39.3%) 5
  • Plasma concentrations not influenced by renal function 1, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Colistin Dosage Administration in Patients with Impaired Renal Function

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Colistin Dosage Guidelines for Patients with Normal Renal Function

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Polymyxin B in Renal Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.